List of Voyager Therapeutics patents

Patent 11931375 was granted and assigned to Voyager Therapeutics on March, 2024 by the United States Patent and Trademark Office.

Patent 11752181 was granted and assigned to Voyager Therapeutics on September, 2023 by the United States Patent and Trademark Office.

Patent 11326182 was granted and assigned to Voyager Therapeutics on May, 2022 by the United States Patent and Trademark Office.

Patent 11434502 was granted and assigned to Voyager Therapeutics on September, 2022 by the United States Patent and Trademark Office.

Patent 10570395 was granted and assigned to Voyager Therapeutics on February, 2020 by the United States Patent and Trademark Office.

Patent 10584337 was granted and assigned to Voyager Therapeutics on March, 2020 by the United States Patent and Trademark Office.

Patent 10920227 was granted and assigned to Voyager Therapeutics on February, 2021 by the United States Patent and Trademark Office.

Patent 11542506 was granted and assigned to Voyager Therapeutics on January, 2023 by the United States Patent and Trademark Office.

Patent 11603542 was granted and assigned to Voyager Therapeutics on March, 2023 by the United States Patent and Trademark Office.

Patent 10335466 was granted and assigned to Voyager Therapeutics on July, 2019 by the United States Patent and Trademark Office.

Patent 10577627 was granted and assigned to Voyager Therapeutics on March, 2020 by the United States Patent and Trademark Office.

Patent 11193129 was granted and assigned to Voyager Therapeutics on December, 2021 by the United States Patent and Trademark Office.

Patent 11198873 was granted and assigned to Voyager Therapeutics on December, 2021 by the United States Patent and Trademark Office.

Patent 10597660 was granted and assigned to Voyager Therapeutics on March, 2020 by the United States Patent and Trademark Office.

Patent 11512327 was granted and assigned to Voyager Therapeutics on November, 2022 by the United States Patent and Trademark Office.

Patent 10983110 was granted and assigned to Voyager Therapeutics on April, 2021 by the United States Patent and Trademark Office.

Patent 11027000 was granted and assigned to Voyager Therapeutics on June, 2021 by the United States Patent and Trademark Office.

Patent 12060567 was granted and assigned to Voyager Therapeutics on August, 2024 by the United States Patent and Trademark Office.

Patent 12116589 was granted and assigned to Voyager Therapeutics on October, 2024 by the United States Patent and Trademark Office.

Patent 11759506 was granted and assigned to Voyager Therapeutics on September, 2023 by the United States Patent and Trademark Office.

Patent 11859200 was granted and assigned to Voyager Therapeutics on January, 2024 by the United States Patent and Trademark Office.

Patent 11975056 was granted and assigned to Voyager Therapeutics on May, 2024 by the United States Patent and Trademark Office.

Patent 12084659 was granted and assigned to Voyager Therapeutics on September, 2024 by the United States Patent and Trademark Office.